MedTrace Logo

Lamotrigine Therapy in Geriatric Bipolar Depression

NCT00720473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2017-02-01

Study results available
· View outcomes & findings →

Summary

We propose to study the efficacy and tolerability of lamotrigine in the treatment of older adults with bipolar depression and to compare measures of brain energy metabolism between older subjects with bipolar depression and healthy age-matched controls in order to better understand treatment response in geriatric bipolar depression.

Conditions

Interventions

DRUG

Lamotrigine

Lamotrigine with dosage range from 25 mg to 200 mg per day.

Sponsors & Collaborators

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Brent P Forester, MD · Mclean Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2011-07-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00720473 on ClinicalTrials.gov